Cátedra UNESCO de Bioética



"License CRISPR patents for free to share gene editing globally"


Universities hold the majority of CRISPR patents. They are in a strong position to ensure that the technology is widely shared for education and research.

This week, Wageningen University and Research in the Netherlands announced that it will allow non-profit organizations to use its CRISPR–Cas9 gene-editing technology for free, for non-commercial applications in food and agriculture. It’s an important development, and another step towards making a technology with untapped potential more accessible — especially for researchers in low- and middle-income countries.